194 filings
Page 3 of 10
6-K
xden ywcz9
8 Jan 24
Evaxion Announces Plan to Implement ADS Ratio Change
8:30am
6-K
bnr66
21 Dec 23
Current report (foreign)
4:45pm
6-K
d9ltzs1yi2sasn
19 Dec 23
Evaxion Announces Business Update and Third Quarter 2023 Financial Results
4:45pm
6-K
u6zdjal 6byf
19 Dec 23
Evaxion Biotech Announces Private Placement Financing
8:45am
6-K
dfcz1a6i h45tt
8 Dec 23
Current report (foreign)
4:45pm
6-K
rqm6sdc fhd
28 Nov 23
Evaxion to Unveil Potentially Groundbreaking AI-Immunology™ Precision Cancer Vaccine Concept
8:27am
6-K
vvlc1lkfs660lm7ezuc
17 Nov 23
Current report (foreign)
9:15am
6-K
tthfq0jx os908de5lke
15 Nov 23
Evaxion Presents Proof-of-Principle for Its Unique AI Model Predicting Responses to Cancer Immunotherapy
8:00am
6-K
yjtn94tg3 w6
6 Nov 23
Current report (foreign)
10:12am
6-K
xcymjm4 3g2mg1a
31 Oct 23
Evaxion Announces Encouraging Initial Phase 2 Clinical Data on Its Personalized Cancer Vaccine EVX-01
11:22am
6-K
1gkav9n
26 Oct 23
New and Exciting Clinical Data on Evaxion’s AI-Immunology™-Based Personalized Cancer Vaccines to be Presented
8:30am
6-K
t4xxfd3h efp6
13 Oct 23
Current report (foreign)
4:45pm
6-K
r5oy2l
5 Oct 23
Evaxion Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
8:30am
6-K
49vbjc b5
27 Sep 23
Current report (foreign)
4:45pm
6-K
scz4h
25 Sep 23
Current report (foreign)
4:45pm
424B4
44dnpqm3
13 Sep 23
Prospectus supplement with pricing info
4:45pm
6-K
odq y9p3xaoix4d4xa
11 Sep 23
Current report (foreign)
8:17am
6-K/A
nxj 4a5gf1g2
7 Sep 23
Current report (foreign) (amended)
4:45pm
EFFECT
za8l3p2wh4zmn4tb
31 Aug 23
Notice of effectiveness
12:15am
6-K
bscksz4ek7zl
29 Aug 23
Evaxion announces Executive Management Changes to strengthen the AI-strategy
9:22am